Precirix Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
43
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$89M
- Investors
-
11
Precirix General Information
Description
Developer of radio-immunotherapeutic drugs designed to offer a new generation of targeted cancer therapies. The company's drugs are based on the camelid immune system which uses antigen-binding fragments to transport therapeutic radioisotopes to selected target receptors on the cancer cell surface, enabling patients to receive personalized cancer medicine.
Contact Information
Website
www.precirix.comCorporate Office
- Burgemeester Etienne Demunterlaan 3
- 1090 Brussels
- Belgium
Corporate Office
- Burgemeester Etienne Demunterlaan 3
- 1090 Brussels
- Belgium
Precirix Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Later Stage VC (Series B) | 16-Mar-2022 | $89M | Completed | Clinical Trials - Phase 2 | ||
7. Grant | 01-Jan-2019 | Completed | Clinical Trials - Phase 1 | |||
6. Early Stage VC (Series A) | 16-Nov-2018 | Completed | Clinical Trials - Phase 1 | |||
5. Early Stage VC | 24-Oct-2017 | Completed | Startup | |||
4. Grant | 01-Dec-2015 | Completed | Startup | |||
3. Grant | 01-Dec-2014 | Completed | Startup | |||
2. Capitalization | 01-Oct-2014 | $79.1K | $79.1K | Completed | Startup | |
1. University Spin-Out | 01-Jan-2014 | Completed | Startup |
Precirix Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Preference B Shares | ||||||||
Preference A Shares | ||||||||
Ordinary | 15,000 | $110.83 | $110.83 | 1x | $110.83 | 5.11% |
Precirix Comparisons
Industry
Financing
Details
Precirix Competitors (33)
One of Precirix’s 33 competitors is Kite Pharma, a Formerly VC-backed company based in Santa Monica, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Kite Pharma | Formerly VC-backed | Santa Monica, CA | ||||
Genprex | Formerly VC-backed | Austin, TX | ||||
Light Chain Bioscience | Private Equity-Backed | Geneva, Switzerland | ||||
Loxo Oncology | Formerly VC-backed | Stamford, CT | ||||
Aileron Therapeutics | Formerly VC-backed | Watertown, MA |
Precirix Patents
Precirix Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-3192297-A1 | Reactions of radioactive compounds facilitated by a solid phase | Pending | 11-Sep-2020 | ||
EP-3967674-A1 | Reactions of radioactive compounds facilitated by a solid phase | Pending | 11-Sep-2020 | ||
AU-2021340192-A1 | Reactions of radioactive compounds facilitated by a solid phase | Pending | 11-Sep-2020 | ||
EP-4211099-A1 | Reactions of radioactive compounds facilitated by a solid phase | Pending | 11-Sep-2020 | ||
US-20230382855-A1 | Reactions of radioactive compounds facilitated by a solid phase | Pending | 11-Sep-2020 | C07D207/46 |
Precirix Signals
Precirix Investors (11)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Forbion | Venture Capital | Minority | ||
Inkef | Venture Capital | Minority | ||
Jeito | Growth/Expansion | Minority | ||
BioMedPartners | Venture Capital | Minority | ||
Gimv | PE/Buyout | Minority |
Precirix FAQs
-
When was Precirix founded?
Precirix was founded in 2014.
-
Where is Precirix headquartered?
Precirix is headquartered in Brussels, Belgium.
-
What is the size of Precirix?
Precirix has 43 total employees.
-
What industry is Precirix in?
Precirix’s primary industry is Biotechnology.
-
Is Precirix a private or public company?
Precirix is a Private company.
-
What is the current valuation of Precirix?
The current valuation of Precirix is
. -
What is Precirix’s current revenue?
The current revenue for Precirix is
. -
How much funding has Precirix raised over time?
Precirix has raised $133M.
-
Who are Precirix’s investors?
Forbion, Inkef, Jeito, BioMedPartners, and Gimv are 5 of 11 investors who have invested in Precirix.
-
Who are Precirix’s competitors?
Kite Pharma, Genprex, Light Chain Bioscience, Loxo Oncology, and Aileron Therapeutics are some of the 33 competitors of Precirix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »